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Abstract (Words=248) 89 
Background. Pancreatic cancer (PC) is a highly fatal cancer with currently limited 90 
opportunities for early detection and effective treatment. Modifiable factors may offer 91 
pathways for primary prevention. In this study, the association between the healthy lifestyle 92 
index (HLI) and PC risk was examined. 93 
Methods. Within the European Prospective Investigation into Cancer and Nutrition (EPIC) 94 
cohort, 1,113 incident PC (57% women) were diagnosed from 400,577 cancer-free participants 95 
followed-up for 15 years (median). HLI scores combined smoking, alcohol intake, dietary 96 
exposure, physical activity and, in turn, overall and central adiposity using BMI (HLIBMI) and 97 
waist-to-hip ratio (WHR, HLIWHR), respectively. High values of HLI indicate adherence to 98 
healthy behaviors. Cox proportional hazard models with age as primary time variable were 99 
used to estimate PC hazard ratios (HR) and 95% confidence intervals (CI). Sensitivity analyses 100 
were performed by excluding, in turn, each factor from the HLI score. Population attributable 101 
fractions (PAF) were estimated assuming participants’ shift to healthier lifestyles.  102 
Results. The HRs for a one-standard deviation increment of HLIBMI and HLIWHR were 0.84 103 
(95% CI: 0.79, 0.89; ptrend=4.3e-09) and 0.77 (0.72, 0.82; ptrend=1.7e-15), respectively. 104 
Exclusions of smoking from HLIWHR resulted in HRs of 0.88 (0.82, 0.94; ptrend=4.9e-04). The 105 
overall PAF estimate was 19% (95% CI: 11%, 26%), and 14% (6%, 21%) when smoking was 106 
removed from the score.  107 
Conclusion. Adherence to a healthy lifestyle was inversely associated with PC risk, beyond 108 
the beneficial role of smoking avoidance. Public health measures targeting compliance with 109 
healthy lifestyles may have an impact on PC incidence.   110 
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Introduction (Words=4,134) 111 
In the last decades, the rise in pancreatic cancer (PC) incidence has become a major public 112 
health concern with mortality rates expected to double by 2030 in American and European 113 
populations [1–3]. Commonly diagnosed at late stages, PC is a highly fatal cancer with similar 114 
incidence and mortality rates [4]. In the current absence of available screening tools [5], the 115 
identification of modifiable risk factors might be important for PC prevention. 116 
The World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) 117 
international expert panel estimated that at least one-third of all cancers could have been 118 
prevented through lifestyle management including diet, obesity and physical activity habits [6]. 119 
PC incidence rates are nearly four times higher in high-income countries such as the United 120 
States and Western European countries than in middle- and low-income countries [4], 121 
suggesting that PC occurrence may be associated with lifestyle factors specifically prevalent 122 
in the Western world. Individual examination of lifestyle risk factors of PC have led to the 123 
identification of smoking, as well as body fatness, adult attained height, type-2 diabetes, and 124 
heavy alcohol drinking as positive risk factors, while diet and physical activity have been 125 
inconsistently associated with PC risk [7,8]. There is limited evidence regarding the joint 126 
association of different lifestyle factors on PC incidence, especially among European 127 
populations [9,10]. 128 
Previous epidemiological studies have identified clusters of modifiable exposures, assessable 129 
through a priori scores reflecting compliance with primary prevention guidelines [11], which 130 
were evaluated in relation to cardiovascular diseases [12,13], cancer incidence [14,15], and 131 
overall and cause-specific mortality [16,17]. A multi-component score termed the Healthy 132 
Lifestyle Index (HLI), combining information on smoking, alcohol intake, dietary habits, body 133 
mass index (BMI), and physical activity has been previously related to colorectal [18], breast 134 
[19], gastric [20], and overall cancers [21] within the European Prospective Investigation into 135 
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Cancer and Nutrition (EPIC) study. Within the American Association of Retired Persons 136 
(AARP) study a strong inverse association was observed between the HLI and PC risk[9].  137 
In this work, the association between the HLI and PC risk was examined within the EPIC study. 138 
Two versions of the score were used, i.e. (i) with BMI to reflect overall adiposity and (ii) with 139 
waist-to-hip ratio to reflect central adiposity. The marginal role of single factors in the HLI 140 
score was investigated, particularly smoking. Population attributable fractions were also 141 
estimated.  142 
 143 
Material and Methods 144 
Study population. EPIC is a multicenter prospective study designed to investigate the etiology 145 
of cancer in relation to diet and other lifestyle factors [22]. From 1992 to 2000, 521,324 146 
participants aged from 35 to 70 years were recruited across 10 European countries, mostly from 147 
the general population, of which 70% were women. Exceptions were the French cohort (school 148 
and university employees), the Spanish and Italian centers (blood donors), Utrecht and 149 
Florence centers (breast cancer screening participants), and Oxford (vegetarians and ‘health 150 
conscious’ participants). In France, Utrecht and Naples women only were recruited. Study 151 
participants provided informed consent before completing questionnaires at baseline. 152 
Participants from Norway were excluded from this study, as information on physical activity 153 
was not compatible with the other centers [23].  154 
Cancer cases were identified during follow-up based on population cancer registries in 155 
Denmark, Italy, Netherlands, Spain, Sweden, and the United Kingdom, and on a combination 156 
of methods, including health insurance records, contacts with cancer and pathology registries, 157 
and active follow-up of EPIC participants and their next of kin in France, Germany, and Greece. 158 
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Mortality data were collected from, either the cancer or mortality registries at the regional or 159 
national level.  160 
The most recent vital status and cancer diagnosis update were used. Vital status was known for 161 
98.4% of all EPIC subjects, while 1.6% of participants emigrated, withdrew or were lost to 162 
follow-up. The current follow-up period ended as follows: December 2009 in Varese and 163 
Murcia, December 2010 in Florence, Ragusa, Turin, Asturias, Bilthoven and Utrecht, 164 
December 2011 in Granada, Navarra, San Sebastian and Cambridge, December 2012 in 165 
Oxford, Umeå, and Denmark, and December 2013 in Malmö. The end of follow-up was 166 
considered as the last known contact with participants in France (June 2008), Heidelberg and 167 
Potsdam (December 2009), and Naples (December 2010) and Greece (December 2012). Cases 168 
of PC were primary incident tumor of the pancreas, coded according to the International 169 
Classification of Diseases (10th edition), which included all invasive pancreatic cancers 170 
(C25.0–C25.3, C25.7–C25.9). Endocrine and neuroendocrine tumors of the pancreas (C25.4) 171 
were censored at date of diagnosis (n=54). Microscopically confirmed PC represented 83% of 172 
the cases (n=928) based on histology of the primary tumor or metastases, cytology or autopsy 173 
reports.  174 
Exposure assessment. Habitual diet, including alcohol intake, over the year preceding 175 
recruitment was assessed at baseline by validated center-specific dietary questionnaires 176 
[22,24]. Data on anthropometry (self-reported in France and the UK Oxford center) [25,26] 177 
physical activity, smoking habits, and prevalent chronic conditions were collected at 178 
recruitment through lifestyle questionnaires [22]. 179 
A diet score was built from the combination of six dietary factors reflecting diet quality [21], 180 
i.e. cereal fibers, red and processed meat, the ratio of polyunsaturated to saturated fatty acids, 181 
margarine (to express industrially produced trans-fats) [27,28], glycemic load, and fruits and 182 
vegetables. For each dietary factor, residuals were computed in models with total energy intake 183 
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[29], and grouped into country-specific deciles. Individual scores were summed up and 184 
categorized into quintiles. 185 
The HLI was generated from the combination of five lifestyle factors, namely: diet score, 186 
physical activity, smoking status, alcohol consumption and anthropometry. For each factor, 187 
scores ranging from 0 to 4 were assigned to increasingly healthier categories, as described in 188 
Figure 1. The HLI was obtained as the sum of scores of each lifestyle factor [19]. As previous 189 
evidence on PC etiology identified waist-to-hip ratio, an indicator of central adiposity, as a PC 190 
risk factor [30,31], a HLI based on WHR (HLIWHR) was implemented replacing BMI with sex-191 
specific WHR quintiles.  192 
Statistical analysis. From a study population of 521,324 participants, subjects without lifestyle 193 
or dietary information (n= 6,902), with ratio of estimated energy intake over energy 194 
requirement in the top or bottom 1% (n=10,241),[32] with self-reported prevalent cancer 195 
(n=24,221), with missing follow-up information (n=3,800), with missing smoking status 196 
(n=15,684) or physical activity (n=65,054) were excluded. For analyses with HLIWHR, subjects 197 
with missing WHR were also excluded (n=45,105). Country-specific age standardized PC 198 
incidence rates (ASR, per 100,000 person-years, PY) were computed using 5-year categories 199 
in the range 50 to 70 years and the standard European population. 200 
The association between the HLI and PC incidence was evaluated using multivariable Cox 201 
proportional hazard models, with age as the primary time variable, and Breslow’s method to 202 
handle ties [33]. The time at study entry was age at recruitment, while the exit time was age at 203 
cancer diagnosis, death, loss, or end of follow-up, whichever came first. All models were 204 
stratified by study center [32], sex and age at recruitment in 1-year categories.  205 
The HLIBMI and HLIWHR were, in turn, modeled as continuous variables to compute HR 206 
estimates for a one-standard deviation (1-SD), corresponding to about three-point increase in 207 
the score. Analyses were also carried out in categories (0-4, 5-9, 10-14, 15-20), using the group 208 
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5-9 as reference. Models were systematically adjusted for potential risk factors of PC and 209 
covariates influencing HLI and PC risk [21,34–36], namely education level (no degree/primary 210 
school, secondary/technical or professional school, university degree or more, unknown (4%)), 211 
self-reported baseline diabetes status (no, yes, unknown (8%)), energy intake from non-alcohol 212 
sources (continuous), and height (continuous). Additional adjustment for BMI (continuous) 213 
was used in models for HLIWHR. HRs were unchanged after women-specific inclusion of 214 
menopausal status, ever use of replacement hormonal replacement therapy and number of full-215 
term pregnancies, thus adjustment for these variables was not pursued. Overall tests for 216 
statistical significance of HRs were determined by comparing Wald-test statistics to a χ² 217 
distribution with degree of freedom (dof) equal to the number of categories minus one for 218 
evaluation in categories (pWald) and dof equal to one as continuous (ptrend). The proportionality 219 
of hazards (PH) assumption was evaluated through the Schoenfeld’s residuals [37]. 220 
Sensitivity analyses were carried out by excluding, in turn, each factor from the HLI scores to 221 
identify factors mostly driving the HLI association with PC risk. The excluded component was 222 
used as a confounder in the model. 223 
Assuming a causal relationship between HLIWHR and PC risk, population attributable fractions 224 
(PAF) were estimated as the reduction in PC incidence that would occur if study participants 225 
shifted to the adjacent healthier category of HLIWHR, as [38] 226 
𝑃𝑃𝑃𝑃𝑃𝑃 =
∑ 𝑅𝑅𝑅𝑅𝑖𝑖 𝑐𝑐𝑖𝑖𝑘𝑘𝑖𝑖=1 − ∑ 𝑅𝑅𝑅𝑅𝑖𝑖  𝑐𝑐𝑖𝑖∗𝑘𝑘𝑖𝑖=1
∑ 𝑅𝑅𝑅𝑅𝑖𝑖 𝑐𝑐𝑖𝑖𝑘𝑘𝑖𝑖=1
, 227 
with i=1,…,4 indexing the HLIWHR categories, HRi and ci expressing the hazards ratio and the 228 
observed proportion of participants in category i, respectively, and ci* the counterfactual 229 
proportion of participants, as detailed in Supplementary Table 1. PAF was also computed 230 
assuming a counterfactual scenario whereby men adopted women’s lifestyle habits. Given the 231 
low PC prevalence and under the proportional hazards assumption, HRs were correct 232 
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approximations of risk ratios (RRi). Confidence intervals were obtained using bootstrap 233 
sampling [39]. 234 
The relationship between the HLI and PC risk was estimated by, in turn, sex, European regions 235 
(North: Denmark, Sweden; Central: The United Kingdom, The Netherlands, Germany; South: 236 
France, Greece, Italy, and Spain), and smoking status (never, former, current). Interactions 237 
were evaluated by comparing the difference in log-likelihood of models with and without 238 
interaction terms between HLIWHR and, either sex, European region or smoking, to a χ² 239 
distribution, with dof equal to the total number of interaction terms minus one. Although the 240 
PH assumption was satisfied, possible selections could operate among study participants within 241 
15 year of follow-up, and HR estimates can change with age. The pattern of HR for a 1-SD 242 
increase of HLIWHR by age was examined using a flexible parametric survival model on the 243 
cumulative hazard scale. Restricted cubic splines with 5 internal knots were used to model the 244 
baseline hazard using attained age as the time scale and a time-varying coefficient on HLIWHR 245 
[40].  246 
To address potential reverse causality, analyses were carried out excluding the first 2 and 5 247 
years of follow-up. In analyses excluding smoking from the HLI, HR estimates after adjustment 248 
by smoking status (never, former, current), smoking intensity (number of cigarette/day, 249 
continuous) and duration of smoking (years, continuous) were examined. Two-sided p-values 250 
were used with a 5% nominal statistical significance. Analyses were performed using Stata 14 251 
[41].  252 
 253 
Results 254 
From a total of 400,577 participants (70% women) followed-up for 15 years (median) and a 255 
total of 5,544,627 person-years, 1,113 incident PC cases were diagnosed. Exclusion of subjects 256 
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without information on their WHR led to 1,075 PC cases from a total of 355,472 participants 257 
as reported in Table 1. The overall PC ASR was equal to 6.0 per 100,000 person-years, with 258 
relatively large and low ASR estimates observed in Germany (9.4 per 100,000 PY) and France 259 
(2.1 per 100,000 person-years), respectively. The individual components of the HLI, together 260 
with other confounding variables, are described in Table 2. The HLI was inversely related to 261 
education, while the prevalence of diabetes at recruitment was stable across HLI categories. 262 
The hypothesis of PH assumption was not rejected with p-value equal to 0.24. 263 
A 1-SD higher HLI was inversely associated with PC risk, with HR equal to 0.84 (95%CI: 264 
0.79, 0.89, ptrend=4.3e-09) for HLIBMI and 0.77 (0.72, 0.82, ptrend=1.7e-15) for HLIWHR, as 265 
shown in Table 3. These patterns were confirmed for PC HR estimates for analyses in 266 
categories, consistently for HLIBMI and HLIWHR.  267 
Results of sensitivity analyses are displayed in Figure 2. After exclusion of smoking status, 268 
the HR for a 1-SD increase of HLIBMI was 0.94 (95%CI: 0.88, 1.01; ptrend=0.11), and after 269 
exclusions of, in turn, alcohol and BMI, HRs were 0.85 (0.80, 0.91; ptrend=6.3e-07) and 0.79 270 
(0.74, 0.85; ptrend=7.6e-12), respectively. After exclusion of, in turn, smoking, alcohol, waist-271 
to-hip ratio from the HLIWHR score, HRs were equal to 0.88 (0.82, 0.94; ptrend=4.9e-04), 0.79 272 
(0.74, 0.84; ptrend=7.0e-13) and 0.79 (0.74, 0.85; ptrend=3.2e-11), respectively. 273 
PAF estimates for a shift of participants to the adjacent healthier category of HLIWHR was equal 274 
to 19% (95%CI: 11%, 26%) (Table 4). Excluding, in turn, smoking, alcohol and WHR from 275 
the HLIWHR showed PAF estimates of 14% (6%, 21%), 19% (10%, 25%), and 16% (9%, 22%), 276 
respectively. PAF were 8% (-3%, 18%) for non-smokers at baseline (never and former) and 277 
20% (7%, 35%) for current smokers. PAF estimates were 29% (16%, 37%) in men, and 13% 278 
(2%, 24%) in women. Counterfactual scenario whereby men adopted women’s lifestyle habits 279 
showed a PAF of 13% (9%, 26%). 280 
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The association between the HLIWHR and PC risk were similar by sex, European region, and 281 
smoking status with pheterogeneity equal to 0.35, 0.15 and 0.62, respectively (Figure 3). Although 282 
the PH assumption was satisfied, PC HR estimates for HLIWHR showed weaker associations at 283 
older ages (Figure 4). Exclusion of the first 2 and 5 years of follow-up did not materially alter 284 
HRs. After exclusion of smoking from the HLI and adjustment by smoking status, intensity 285 
and duration, HRs were unchanged (not shown).  286 
 287 
Discussion 288 
In this large European prospective study, healthy lifestyle habits expressed as a HLI score were 289 
strongly inversely related to the risk of PC. Adherence to healthy behaviors corresponding to a 290 
three-point increase in the score was associated with a 16% (95%CI: 11%, 21%) lower PC risk 291 
for a score that included BMI, and 23% (18%, 28%) lower PC risk for a score based on WHR. 292 
These results support the adoption of healthy lifestyles in PC prevention. 293 
 Scores reflecting dietary and lifestyle habits have become increasingly popular in cancer 294 
epidemiology research [21,42,43]. In EPIC, scores expressing adherence to either the 295 
Mediterranean diet or the WCRF/AICR recommendations have mainly focused on diet, 296 
physical activity and anthropometry, and had previously shown null associations with PC risk 297 
in both men and women [44,45]. Within the NIH-AARP study, a score based on the American 298 
Cancer Society recommendations including physical activity, diet, BMI, alcohol, but not 299 
smoking, was associated with a 20% (95%CI: 3%, 35%) lower PC risk in men, comparing the 300 
top vs. bottom category, while no association was observed in women [46]. Within the same 301 
cohort, an inverse association was observed between HLI and PC, when smoking was added 302 
to the score [9].  303 
In the current study, a comprehensive evaluation of the association between HLI and PC risk 304 
was undertaken using sensitivity analyses. As smoking is an established strong risk factor of 305 
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PC [47], it has been suggested that the association between lifestyle habits and PC might be 306 
primarily driven by smoking [45]. In our analysis, HLI was inversely associated with PC risk 307 
even after excluding smoking from the score, with a 12% risk reduction associated with a three-308 
point (1-SD) increase in the HLIWHR (95%CI: 6%, 18%; ptrend=4.9e-04). Additionally, in never 309 
and former smokers, the PC HR for a three-point increase in the HLI was equal to 0.87 (0.79, 310 
0.95; ptrend=2.0e-03, data not shown), suggesting the advantage of adopting healthy habits for 311 
PC prevention, beyond the benefit of smoking avoidance.  312 
Body fatness is also an established risk factor for PC [8,48]. A recent pooled analysis concluded 313 
that central adiposity during adulthood assessed through waist circumference, or waist-to-hip 314 
ratio may also predict PC risk independently from BMI [49]. In our study, HLI based on WHR 315 
showed a marginally stronger relationship with PC risk than HLI based on BMI. The 316 
subcutaneous truncal adipose tissue has been positively associated with the development of 317 
insulin resistance and diabetes [31,50,51], two recognized risk factors for PC [52], and may 318 
explain the role of central adiposity, rather than overall adiposity, in PC etiology. Moreover, 319 
smoking and alcohol consumption have been previously associated with increasing visceral fat 320 
deposition [53,54], which may suggest common pathways between smoking, alcohol 321 
consumption and central adiposity in pancreas carcinogenesis. 322 
In our study, the association between HLI and PC was marginally stronger at younger ages 323 
compared to older ages. This pattern could be due to a depletion overtime of participants 324 
susceptible to PC [55], a phenomenon resulting in an over representation of non-susceptible 325 
participants with adverse lifestyle profiles at older ages, thus leading to weaker relationships. 326 
Alternatively, HR patterns could be ascribed to study participants’ changes towards healthier 327 
lifestyle habits related to ageing, or ultimately due to a true causal association indicating that 328 




This study is to date the first evaluation of the association between a combination of healthy 331 
lifestyle factors and PC incidence in European populations, thus corroborating previous 332 
evidence from a US study [9]. The strengths of the present study rely on its prospective multi-333 
country design reflecting heterogeneous lifestyle habits. Its large sample size and long follow-334 
up time allowed ascertainment of over a thousand incident PC cases, increasing the statistical 335 
power in comparison with the previous EPIC evaluation [44]. Furthermore, associations were 336 
unchanged after exclusion of the first years of follow-up. However, this study also has 337 
limitations. First, measurement errors likely affected dietary and lifestyle assessments, possibly 338 
introducing bias in estimated associations. Furthermore, as EPIC participants represent a 339 
healthy proportion of the general population, risk estimates in our study were likely attenuated. 340 
In addition, the evidence for a role of life course socio-economic status on cancer-related risk 341 
factors was suggested [57], and the use of education in our study as a proxy for socio-economic 342 
status might have introduced residual confounding. Last, our study did not consider potential 343 
changes in dietary and lifestyle exposures after recruitment, which could be relevant to estimate 344 
the association between lifestyle factors and PC risk, as well as to explain HR patterns over 345 
age.  346 
Assuming that HLI was causally related to PC risk, and that combinations of different lifestyle 347 
factors leading to the same value of the HLI had the same effect on PC risk, PAF estimates 348 
indicated that 14% (95%CI: 6%, 21%) of PC could have been avoided by controlling central 349 
adiposity, alcohol consumption, diet and physical activity, and up to 19% (11%, 26%) if 350 
smoking control was also implemented, indicating the benefit of adopting healthy lifestyle 351 
beyond smoking control. In the AARP study, the PAF was 27% assuming that participants 352 
adopted the healthiest lifestyle pattern [9], while in a recent Australian PC study considering 353 





In conclusion, our findings provide evidence that adherence to a combination of healthy 357 
lifestyle habits was strongly inversely associated with PC risk in European adults. Inverse 358 
associations were observed even after dismissing, in turn, smoking, alcohol drinking, and 359 
adiposity. Adherence to healthy lifestyle habits, especially from younger ages, could be an 360 
effective primary prevention strategy to control the incidence of PC, a fatal cancer with no 361 
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Figures Captions  
 
Fig 1 Scoring system implemented to combine the 5 lifestyle factors into the Heathy Lifestyle 
Index based on the waist-to-hip ratio (HLIWHR) 
 
1 For the HLIBMI, sex-specific waist-to-hip ratio quintiles was replaced by categories of BMI at 
baseline using cut-offs as (4) 22–23.9 kg.m-2, (3) 24–25.9 kg.m-2, (2) <22 kg.m-2, (1) 26–




Fig 2 Hazard ratio estimates for the associations between a 1-SD increment of HLI1 and PC 
risk after recalculation of the HLIBMI and the HLIWHR excluding, in turn, each lifestyle factor 
 
1 One Standard deviation corresponded to about 3 units of either HLIBMI or HLIWHR; 
2 Models evaluating associations between the HLIBMI and PC risk were adjusted for education 
level, diabetes status, non-alcohol energy intakes, height, and the index components currently 
excluded from the calculation of the HLI, and stratified by study center, age and sex;  
3 Models evaluating associations between the HLIWHR and PC risk were adjusted for education 
level, diabetes status, non-alcohol energy intakes, height, BMI and the index components 
currently excluded from the calculation of the HLI, and stratified by study center, age and sex. 
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Fig 3 Heterogeneity in the relationship between HLIWHR and PC by sex, European region, and 
smoking status, expressed for a 1-SD increase of HLIWHR1 
 
1 One Standard deviation corresponded to about 3 units of either HLIBMI or HLIWHR; 
2 Northern Europe included Denmark and Sweden, Central Europe included United Kingdom, 
The Netherlands and Germany, and Southern Europe included France, Greece, Italy and Spain; 
3 Models were computed using the HLIWHR excluding smoking; 
4 Models included interaction terms between HLIWHR and, in turn, sex, European region, and 
smoking status at recruitment. Differences in HRs were assessed comparing the log-likelihood 
of models with and without interaction terms to a χ2 distribution with degrees of freedom equal 
to the number of categories minus one. 
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Fig 4 Hazard ratio function (and 95%CI)1 for the association between HLIWHR and PC risk 
over years of age, for 1-SD increase of HLIWHR 
 
1 Obtained from a flexible parametric survival model using restricted cubic splines with 5 
internal knots and a time-varying coefficient on HLIWHR. Model was adjusted for educational 
level, BMI, height, non-alcohol energy intake, diabetes status, sex, country, age at recruitment. 
